Market by Application, Component, and Country | Forecast 2021-2028
Triton’s report has established that the precision medicine market in North America is estimated to develop at a CAGR of 9.60% in the period 2021-2028.
The countries studied in this market are:
• United States
• Canada
Several diagnostics manufacturers are concentrating on expanding their product portfolio in NGS-based molecular diagnostics. This has led manufacturers to collaborate with service providers and pharmaceutical giants to offer molecular diagnostics, along with their complementary precision medicine solutions. These steps are expected to fuel the growth of the reviewed market.
Furthermore, in the United States, the government is taking numerous initiatives to develop precision drugs and tests. Moreover, the government is funding multiple start-ups in molecular diagnostics and precision medicine, contributing to the considered market evolution. The Advancing Standards for Precision Medicine was launched to detect and recommend numerous wearable, sensor, and social determinants for the standardization of health data. This led to an increased awareness relating to the effectiveness of precision medicine among the country’s population. The launch of various such programs is likely to increase the demand for precision medicine, in turn, driving the progression of the precision medicine market.
On the other hand, there is a well-developed network of academic centers and researchers, making the country one of the global leaders in precision medicine research. For instance, Genome Canada has funded major innovative projects to implement precision medicine in the healthcare sector. Additionally, the Ontario Personalized Medicine Network is another initiative to help detect critical paths to ensure precision medicine adoption around Ontario. Thus, such initiatives supporting precision medicine implementation are fueling the growth of the precision medicine market in Canada.
Danaher Corporation is a medicine company engaged in designing, manufacturing, and marketing healthcare and industrial equipment. Its business segments include life sciences, diagnostics, dental, and environmental and applied solutions. Besides, the company provides various solutions, including Clinical IVD tests. Founded in 1969, Danaher has its headquarters in Washington DC, the United States.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT
1. NORTH AMERICA PRECISION MEDICINE MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. KEY INSIGHTS
2.1.1. PRESENCE OF BIOPHARMACEUTICAL COMPANIES
2.1.2. INVESTMENTS IN GENE THERAPY
2.2. IMPACT OF COVID-19 ON PRECISION MEDICINE MARKET
2.3. SUPPLY CHAIN OUTLOOK
2.4. REGULATORY POLICIES & FRAMEWORK
2.5. ETYMOLOGY OF PRECISION MEDICINE
2.6. PORTER’S FIVE FORCES MODEL
2.7. MARKET ATTRACTIVENESS INDEX
2.8. VENDOR LANDSCAPE
2.9. KEY MARKET STRATEGIES
2.9.1. CONTRACTS AND PARTNERSHIPS
2.9.2. BUSINESS EXPANSION & DIVESTITURES
2.9.3. ACQUISITIONS & MERGERS
2.9.4. NEW PRODUCT LAUNCHES
2.10. MARKET DRIVERS
2.10.1. HIGH PREVALENCE OF CHRONIC DISEASES IN THE AGING POPULATION
2.10.2. DIGITAL COLLABORATION AMONG RESEARCH GROUPS AND ORGANIZATIONS
2.10.3. IDENTIFICATION OF GENETIC MAKEUP IN THE HUMAN GENOME
2.11. MARKET CHALLENGES
2.11.1. STRINGENT DRUG APPROVAL PROCESS
2.11.2. SECURITY THREATS PERTAINING TO DATA SHARING
2.11.3. CHANGES IN REIMBURSEMENT AND REGULATORY PROCESS
2.12. MARKET OPPORTUNITIES
2.12.1. INVESTMETNS BY GOVERNMENT AND PRIVATE PLAYERS IN CANCER TREATMENT
2.12.2. DEMAND FOR PREVENTIVE CARE
3. NORTH AMERICA PRECISION MEDICINE MARKET - BY APPLICATION
3.1. ONCOLOGY
3.2. INFECTIOUS DISEASES
3.3. NEUROLOGY/PHYSIATRY
3.4. CARDIOVASCULAR
3.5. LIFESTYLE AND ENDOCRINOLOGY
3.6. GASTROENTEROLOGY
3.7. OTHER APPLICATIONS
4. NORTH AMERICA PRECISION MEDICINE MARKET - BY COMPONENT
4.1. APPLIED SCIENCE
4.1.1. GENOMICS
4.1.1.1. PCR
4.1.1.2. PM NGS
4.1.1.3. GENOME EDITING
4.1.1.4. OTHER GENOMICS TECHNOLOGIES
4.1.2. PHARMACOGENOMICS
4.1.3. OTHER APPLIED SCIENCES
4.2. PRECISION THERAPEUTICS
4.2.1. CLINICAL TRIALS
4.2.2. CELL THERAPY
4.2.3. DRUG DISCOVERY AND RESEARCH
4.2.4. GENE THERAPY
4.3. PRECISION DIAGNOSTICS
4.3.1. MOLECULAR DIAGNOSTICS
4.3.1.1. NON-INVASIVE PRENATAL TESTING (NIPT)
4.3.1.2. COMPANION DIAGNOSTICS
4.3.1.3. LIQUID BIOPSY
4.3.1.4. OTHER MOLECULAR DIAGNOSTICS
4.3.2. MEDICAL IMAGING
4.3.2.1. IMAGING ANALYTICS
4.3.2.2. IMAGING COMPUTER-AIDED DETECTION (CADX)
4.4. DIGITAL HEALTH AND INFORMATION TECHNOLOGY
4.4.1. CLINICAL DECISION SUPPORT SYSTEMS (CDSS)
4.4.2. BIG DATA ANALYTICS
4.4.3. IT INFRASTRUCTURE
4.4.4. GENOMICS INFORMATICS
4.4.5. IN-SILICO INFORMATICS
4.4.6. MOBILE HEALTH
5. NORTH AMERICA PRECISION MEDICINE MARKET – REGIONAL OUTLOOK
5.1. COUNTRY ANALYSIS
5.1.1. UNITED STATES
5.1.2. CANADA
6. COMPETITIVE LANDSCAPE
6.1. ABBOTT LABORATORIES
6.2. ASTRAZENECA PLC
6.3. BIOCRATES LIFE SCIENCES AG
6.4. BIO-RAD LABORATORIES INC
6.5. DANAHER CORPORATION
6.6. EAGLE GENOMICS LTD
6.7. ELI LILLY & COMPANY
6.8. F HOFFMANN-LA ROCHE AG
6.9. INTOMICS
6.10. LABORATORY CORPORATION OF AMERICA HOLDINGS
6.11. NANOSTRING TECHNOLOGIES
6.12. NOVARTIS AG
6.13. PFIZER INC
6.14. QIAGEN NV
6.15. QUEST DIAGNOSTICS INCORPORATED
7. RESEARCH METHODOLOGY & SCOPE
7.1. RESEARCH SCOPE & DELIVERABLES
7.1.1.  OBJECTIVES OF STUDY
7.1.2.  SCOPE OF STUDY
7.2. SOURCES OF DATA
7.2.1.  PRIMARY DATA SOURCES
7.2.2.  SECONDARY DATA SOURCES
7.3. RESEARCH METHODOLOGY
7.3.1.  EVALUATION OF PROPOSED MARKET
7.3.2.  IDENTIFICATION OF DATA SOURCES
7.3.3.  ASSESSMENT OF MARKET DETERMINANTS
7.3.4.  DATA COLLECTION
7.3.5.  DATA VALIDATION & ANALYSIS
TABLE 1:Â Â Â Â Â Â NORTH AMERICA PRECISION MEDICINE MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2:Â Â Â Â Â Â MARKET ATTRACTIVENESS INDEX
TABLE 3:Â Â Â Â Â Â VENDOR LANDSCAPE
TABLE 4:Â Â Â Â Â Â LIST OF CONTRACTS & PARTNERSHIPS
TABLE 5:Â Â Â Â Â Â LIST OF BUSINESS EXPANSIONS & DIVESTITURES
TABLE 6:Â Â Â Â Â Â LIST OF ACQUISITIONS & MERGERS
TABLE 7:Â Â Â Â Â Â LIST OF NEW PRODUCT LAUNCHES
TABLE 8:Â Â Â Â Â Â NORTH AMERICA PRECISION MEDICINE MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 9:Â Â Â Â Â Â NORTH AMERICA PRECISION MEDICINE MARKET, BY COMPONENT, 2021-2028 (IN $ MILLION)
TABLE 10:Â Â Â Â NORTH AMERICA APPLIED SCIENCE MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 11:Â Â Â Â NORTH AMERICA GENOMICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 12:Â Â Â Â NORTH AMERICA PRECISION THERAPEUTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 13:Â Â Â Â NORTH AMERICA PRECISION DIAGNOSTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 14:Â Â Â Â NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 15:Â Â Â Â NORTH AMERICA MEDICAL IMAGING MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 16:Â Â Â Â NORTH AMERICA DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 17:Â Â Â Â NORTH AMERICA PRECISION MEDICINE MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1:Â Â Â Â NORTH AMERICA PRECISION MEDICINE MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
FIGURE 2:Â Â Â Â NORTH AMERICA PRECISION MEDICINE MARKET, BY APPLICATION, 2020 & 2028
FIGURE 3:Â Â Â Â NORTH AMERICA PRECISION MEDICINE MARKET, BY ONCOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 4:Â Â Â Â NORTH AMERICA PRECISION MEDICINE MARKET, BY INFECTIOUS DISEASES, 2021-2028 (IN $ MILLION)
FIGURE 5:Â Â Â Â NORTH AMERICA PRECISION MEDICINE MARKET, BY NEUROLOGY/PHYSIATRY, 2021-2028 (IN $ MILLION)
FIGURE 6:Â Â Â Â NORTH AMERICA PRECISION MEDICINE MARKET, BY CARDIOVASCULAR, 2021-2028 (IN $ MILLION)
FIGURE 7:Â Â Â Â NORTH AMERICA PRECISION MEDICINE MARKET, BY LIFESTYLE AND ENDOCRINOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 8:Â Â Â Â NORTH AMERICA PRECISION MEDICINE MARKET, BY GASTROENTEROLOGY, 2021-2028 (IN $ MILLION)
FIGURE 9:Â Â Â Â NORTH AMERICA PRECISION MEDICINE MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 10:Â NORTH AMERICA PRECISION MEDICINE MARKET, BY COMPONENT, 2020 & 2028
FIGURE 11:Â NORTH AMERICA PRECISION MEDICINE MARKET, BY APPLIED SCIENCE, 2021-2028 (IN $ MILLION)
FIGURE 12:Â NORTH AMERICA APPLIED SCIENCE MARKET, BY GENOMICS, 2021-2028 (IN $ MILLION)
FIGURE 13:Â NORTH AMERICA GENOMICS MARKET, BY PCR, 2021-2028 (IN $ MILLION)
FIGURE 14:Â NORTH AMERICA GENOMICS MARKET, PM NGS, 2021-2028 (IN $ MILLION)
FIGURE 15:Â NORTH AMERICA GENOMICS MARKET, GENOME EDITING, 2021-2028 (IN $ MILLION)
FIGURE 16:Â NORTH AMERICA GENOMICS MARKET, BY OTHER GENOMICS TECHNOLOGIES, 2021-2028 (IN $ MILLION)
FIGURE 17:Â NORTH AMERICA APPLIED SCIENCE MARKET, BY PHARMACOGENOMICS, 2021-2028 (IN $ MILLION)
FIGURE 18:Â BIOMARKERS ROLE IN PHARMACOGENOMICS
FIGURE 19:Â NORTH AMERICA APPLIED SCIENCE MARKET, BY OTHER APPLIED SCIENCES, 2021-2028 (IN $ MILLION)
FIGURE 20:Â NORTH AMERICA PRECISION MEDICINE MARKET, BY PRECISION THERAPEUTICS, 2021-2028 (IN $ MILLION)
FIGURE 21:Â NORTH AMERICA PRECISION THERAPEUTICS MARKET, BY CLINICAL TRIALS, 2021-2028 (IN $ MILLION)
FIGURE 22:Â NORTH AMERICA PRECISION THERAPEUTICS MARKET, BY CELL THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 23:Â NORTH AMERICA PRECISION THERAPEUTICS MARKET, BY DRUG DISCOVERY AND RESEARCH, 2021-2028 (IN $ MILLION)
FIGURE 24:Â NORTH AMERICA PRECISION THERAPEUTICS MARKET, BY GENE THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 25:Â NORTH AMERICA PRECISION MEDICINE MARKET, BY PRECISION DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 26:Â NORTH AMERICA PRECISION DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 27:Â NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY NON-INVASIVE PRENATAL TESTING (NIPT), 2021-2028 (IN $ MILLION)
FIGURE 28:Â NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY COMPANION DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 29:Â NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY LIQUID BIOPSY, 2021-2028 (IN $ MILLION)
FIGURE 30:Â NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY OTHER MOLECULAR DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 31:Â NORTH AMERICA PRECISION DIAGNOSTICS MARKET, BY MEDICAL IMAGING, 2021-2028 (IN $ MILLION)
FIGURE 32:Â NORTH AMERICA MEDICAL IMAGING MARKET, BY IMAGING ANALYTICS, 2021-2028 (IN $ MILLION)
FIGURE 33:Â NORTH AMERICA MEDICAL IMAGING MARKET, BY IMAGING COMPUTER-AIDED DETECTION (CADX), 2021-2028 (IN $ MILLION)
FIGURE 34:Â NORTH AMERICA PRECISION MEDICINE MARKET, BY DIGITAL HEALTH AND INFORMATION TECHNOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 35:Â NORTH AMERICA DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY CLINICAL DECISION SUPPORT SYSTEMS (CDSS), 2021-2028 (IN $ MILLION)
FIGURE 36:Â NORTH AMERICA DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY BIG DATA ANALYTICS, 2021-2028 (IN $ MILLION)
FIGURE 37:Â NORTH AMERICA DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY IT INFRASTRUCTURE, 2021-2028 (IN $ MILLION)
FIGURE 38:Â NORTH AMERICA DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY GENOMICS INFORMATICS, 2021-2028 (IN $ MILLION)
FIGURE 39:Â NORTH AMERICA DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY IN-SILICO INFORMATICS, 2021-2028 (IN $ MILLION)
FIGURE 40:Â NORTH AMERICA DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY MOBILE HEALTH, 2021-2028 (IN $ MILLION)
FIGURE 41:Â UNITED STATES PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 42:Â CANADA PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)